Insights

Güncel Ruhsatlandırma Yönetmeliği ile Neler Değişiyor ve Firmalar Stratejilerini Belirlerken Nelere Dikkat Etmeli?

Action Speaks Louder Than Words: Turkish Regulatory Inspection of the Cosmetic Industry Q2 2021 – Healthcare Series 17

The Regulatory Landscape of the Food Supplement Industry in Türkiye - Healthcare Series 15

Getting High on Medical Treatment: Medical Use of Cannabis and Legal Approach - Healthcare Series 14

Make Up & Buckle Up! A Closer Look at the Cosmetic Industry’s Regulatory Landscape in Türkiye - Healthcare Series 13

Overview of the Licensing Process for Pharmaceuticals in Türkiye - Healthcare Series 12

Data Exclusivity for Pharmaceutical Companies in Türkiye - Healthcare Series 11

The Regulation on Opticianry Institutions Has Been Amended - Healthcare Series 10

The Bolar Exemption in Türkiye - Healthcare Series 9

An Overview of Patent Protection for Pharmaceuticals - Healthcare Series 8

An Important Date to Consider Regarding the Guidance on Applications for Electronic Scientific Meetings and Electronic Product Promotion Meetings - Healthcare Series 7

TİTCK Updates Clinical Trials FAQ - Healthcare Series 6

Product Market Definition in the Pharmaceutical Industry - Healthcare Series 5

The Guideline for Electronic Scientific Meetings and Electronic Product Promotion Meetings Has Been Published by the Turkish Medicine and Medical Devices Agency - Healthcare Series 4

5 Steps to Consider Before Initiating Service Agreement Fees with Healthcare Professionals - Healthcare Series 3

The Disclosure of Transfers of Value by Pharmaceutical Companies in Türkiye - Healthcare Series 2